Prospective phase I-II trial of helical tomotherapy with or without chemotherapy for postoperative cervical cancer patients

Keyphrases

• Helical Tomotherapy 100%
• Phase II Trial 100%
• Invasive Cervical Cancer 100%
• Cervical Cancer Patients 100%
• Without Chemotherapy 100%
• Concurrent Chemotherapy 75%
• Acute Toxicity 75%
• Chronic Toxicity 75%
• Cervical Cancer 50%
• Hematotoxicity 50%
• HDR Brachytherapy 50%
• Postoperative Radiotherapy 50%
• Vesicovaginal Fistula 50%
• Progression-free Survival 25%
• Diarrhea 25%
• Nausea 25%
• Intensity-modulated Radiotherapy 25%
• Tumor Size 25%
• In(III) 25%
• Carboplatin 25%
• Radiotherapy Alone 25%
• Lymphovascular Invasion 25%
• Intestinal Obstruction 25%
• Gastrointestinal Toxicity 25%
• Common Toxicity Criteria 25%
• Disease-free 25%
• Intracavitary 25%
• External Beam Radiotherapy 25%
• Long-term Toxicity 25%
• Anorexia 25%
• Genitourinary Toxicity 25%
• Positive Lymph Nodes 25%
• Taxol 25%
• Pelvic Radiotherapy 25%
• Cervical Stromal Invasion 25%

Medicine and Dentistry

• Tomotherapy 100%
• Cervical Cancer 100%
• Chronic Toxicity 75%
• Radiation Therapy 75%
• High-Dose-Rate Brachytherapy 50%
• Vesicovaginal Fistula 50%
• Neoplasm 25%
• Nausea 25%
• Diarrhea 25%
• Progression Free Survival 25%
• Survival Rate 25%
• Lymph Node 25%
• Intensity Modulated Radiation Therapy 25%
• Carboplatin 25%
• Paclitaxel 25%
• External Beam Radiotherapy 25%
• Lymph Duct 25%
• Small Intestine Obstruction 25%
• Gastrointestinal Toxicity 25%
• Anorexia 25%
• Pelvic Radiotherapy 25%
• Diseases 25%